Cambrian

Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more

Investment Investment

Cambrian Bio reveals new pipeline company with focus on AMPK activation

Biotech Investment Investment

Cambrian BioPharma unveils new pipeline company

Investment

Interviews of 2022: accelerating longevity

Features Innovation

Christian Angermayer on longevity and biotech investment: it’s bouncing back

Biotech Investment Videos

James Peyer: Geroscience evidence is the key to unlocking preventative therapies

Biotech Features

James Peyer on breaking the geroscience dam

Biotech Features

New mTOR player storms into longevity

Biotech Features

Next gen rapalogs – Cambrian Biopharma announces mTOR inhibitors licensing agreement

Biotech Investment